On Invalid Date, Pmv Pharmaceuticals (NASDAQ: PMVP) reported Q4 2023 earnings per share (EPS) of -$0.31, up 27.91% year over year. Total Pmv Pharmaceuticals earnings for the quarter were -$15.76 million. In the same quarter last year, Pmv Pharmaceuticals's earnings per share (EPS) was -$0.43.
As of Q2 2024, Pmv Pharmaceuticals's earnings has grown year over year. Pmv Pharmaceuticals's earnings in the past year totalled -$68.96 million.
What is PMVP's earnings date?
Pmv Pharmaceuticals's earnings date is Invalid Date. Add PMVP to your watchlist to be reminded of PMVP's next earnings announcement.
What was PMVP's revenue last quarter?
On Invalid Date, Pmv Pharmaceuticals (NASDAQ: PMVP) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Pmv Pharmaceuticals's revenue was $0.00.
What was PMVP's revenue growth in the past year?
As of Q2 2024, Pmv Pharmaceuticals's revenue has grown null year over year. Pmv Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.